Listar Investigación y Desarrollo por autor "Arena A."
Mostrando ítems 1-7 de 7
-
Article
Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype (2020)
Tramutola A.; Pupo G.; Di Domenico F.; Barone E.; Arena A.; Lanzillotta C.; Broekaart D.; Blarzino C.; Head E.; Butterfield D.A.; ... (IOS Press, 2016) -
Review
Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism (2020)
Barone E.; Arena A.; Head E.; Butterfield D.A.; Perluigi M. (Elsevier Inc., 2018) -
Article
Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm (2020)
Barone E.; Di Domenico F.; Cassano T.; Arena A.; Tramutola A.; Lavecchia M.A.; Coccia R.; Butterfield D.A.; Perluigi M. (Elsevier Inc., 2016) -
Conference Paper
Increased mammalian target of rapamycin signaling contributes to the accumulation of protein oxidative damage in a mouse model of down's syndrome (2020)
Tramutola A.; Lanzillotta C.; Arena A.; Barone E.; Perluigi M.; Di Domenico F. (S. Karger AG, 2016) -
Article
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome (2020)
Tramutola A.; Lanzillotta C.; Barone E.; Arena A.; Zuliani I.; Mosca L.; Blarzino C.; Butterfield D.A.; Perluigi M.; Di Domenico F. (BioMed Central Ltd., 2018) -
Review
Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer’s disease pathology (2020)
Tramutola A.; Arena A.; Cini C.; Butterfield D.A.; Barone E. (Taylor and Francis Ltd, 2017) -
Article
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome (2020)
Di Domenico F.; Tramutola A.; Barone E.; Lanzillotta C.; Defever O.; Arena A.; Zuliani I.; Foppoli C.; Iavarone F.; Vincenzoni F.; ... (Elsevier B.V., 2019)